These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8009238

  • 1. Biochemical measurements in Paget's disease of bone.
    Russell RG, Colwell A, Hannon RA, Blumsohn A, al-Dehaimi AW, Assiri AM, Peel NF, Eastell R.
    Semin Arthritis Rheum; 1994 Feb; 23(4):240-1. PubMed ID: 8009238
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diphosphonates in Paget's disease.
    Russell RG, Smith R, Preston C, Walton RJ, Woods CG.
    Lancet; 1974 May 11; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Paget's disease of bone with porcine calcitonin.
    Eisman JA, Xipell JM, Sloman JG, Jerums G, Martin TJ.
    Med J Aust; 1974 Apr 13; 1(15):564-8. PubMed ID: 4858264
    [No Abstract] [Full Text] [Related]

  • 6. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
    Sharp CA, Worsfold M, Rowlands PR, Davie MW.
    Semin Arthritis Rheum; 1994 Feb 13; 23(4):242-3. PubMed ID: 8009239
    [No Abstract] [Full Text] [Related]

  • 7. [Use of biochemical markers of bone turnover in Paget's disease of bone].
    Vignot E, Meunier PJ.
    Ann Biol Clin (Paris); 2001 Feb 13; 59(3):309-11. PubMed ID: 11397680
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alendronate in the treatment of Paget's disease of bone.
    Khan SA, Vasikaran S, McCloskey EV, Benéton MN, Rogers S, Coulton L, Orgee J, Coombes G, Kanis JA.
    Bone; 1997 Mar 13; 20(3):263-71. PubMed ID: 9071478
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R.
    Bone; 1999 May 13; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract] [Full Text] [Related]

  • 14. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
    Raab W, Czitober H.
    Wien Klin Wochenschr; 1967 Feb 03; 79(5):91-3. PubMed ID: 5591364
    [No Abstract] [Full Text] [Related]

  • 15. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.
    de la Piedra C, Rapado A, Díaz Diego EM, Díaz Martín MA, Aguirre C, López Gavilanes E, Díaz Curiel M.
    Calcif Tissue Int; 1996 Aug 03; 59(2):95-9. PubMed ID: 8687976
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment.
    Coulton LA, Preston CJ, Couch M, Kanis JA.
    Arthritis Rheum; 1988 Sep 03; 31(9):1142-7. PubMed ID: 3048274
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972 Sep 03; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mithramycin in Paget's disease.
    Epstein S.
    S Afr Med J; 1974 Jun 09; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of patients with advanced Paget's disease of bone with two cycles of gallium nitrate.
    Bockman RS, Bosco B.
    Semin Arthritis Rheum; 1994 Feb 09; 23(4):268-9. PubMed ID: 8009250
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.